XBIO

Xenetic Biosciences, Inc.

2.35

USD

XBIO Earnings Reports

Positive Surprise Ratio

XBIO beat 15 of 26 last estimates.

58%

Next Report

Date of Next Report

Mar 16, 2026

Estimate for Q4 25 (Revenue/ EPS)

$703.80K

-$0.53

Implied change from Q3 25 (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

+8.61%

-22.06%

Xenetic Biosciences, Inc. earnings per share and revenue

On Nov 10, 2025, XBIO reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.49 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 642.60 thousand, with a --% difference.

Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.53 USD, with revenue projected to reach 703.80 thousand USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were Xenetic Biosciences, Inc.'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Xenetic Biosciences, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Xenetic Biosciences, Inc.'s Q3 2025 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Xenetic Biosciences, Inc. expected to report next?

The next earning report is scheduled for Mar 16, 2026.

What are the forecasts for Xenetic Biosciences, Inc.'s next earnings report?

Based on 3 analysts, Xenetic Biosciences, Inc. is expected to report EPS of -$0.53 and revenue of $703.80K for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.